What quality tests are needed for peptide products?

For peptide products, "quality" means fitness for the intended purpose: the product must consistently meet defined specifications for identity, purity, quantity, and safety. The tests a healthcare organization should consider depend heavily on the intended use (research-only vs. clinical/compounding vs. consumer therapy), but the core analytical toolkit is similar.

• Identity confirmation: mass spectrometry (ESI-MS or MALDI-TOF) to confirm molecular weight, and amino-acid analysis or peptide sequencing to verify the sequence.
• Purity and impurities: reverse-phase HPLC (UV) for purity percentage, plus HPLC-MS for impurity profiling; related substances, deletion sequences, and truncated fragments should be quantified.
• Counter-ion and salt form: ion chromatography or titration to confirm acetate, TFA, or chloride content, since salt form affects solubility and dosing.
• Water content: Karl Fischer titration for lyophilized powders.
• Residual solvents and reagents: GC or GC-MS for synthesis solvents (e.g., DMF, DCM), and tests for residual TFA or coupling reagents.
• Microbiological safety: sterility testing, bacterial endotoxin (LAL) testing, and bioburden for injectable or clinical-use products.
• Particulate matter and visual inspection: important for injectables and reconstituted vials.
• Heavy metals and elemental impurities: ICP-MS where relevant.
• Stability and potency: stability-indicating assays over time, plus a bioassay or binding assay when biological activity matters.
• Documentation: certificate of analysis (CoA), batch records, and chain-of-custody documentation.

How requirements differ by intended use: research-use-only (RUO) peptides typically need identity, HPLC purity, MS confirmation, and a CoA, but not sterility or endotoxin. Clinical or compounded products need the full panel plus sterility, endotoxin, particulate testing, and stability data. Consumer-facing therapy products should additionally have batch-level CoAs, third-party verification, and clear labeling. Healthcare organizations should match the test panel to risk: higher-risk injectables warrant more rigorous microbiology and stability testing, while topical or cosmetic peptides may need fewer microbiological tests but still require identity and purity data.

When selecting suppliers or partners for these quality requirements, buyers can use our services to compare and evaluate Chinese peptide API factories, Chinese research-peptide raw material factories, Chinese lyophilized vial factories, and Chinese dual-chamber cartridge freeze-drying equipment suppliers, as well as to compare and evaluate Chinese peptide international logistics providers. We also offer business, legal, and customs-clearance consulting plus double-clearance tax-included cross-border logistics for peptide international trade.

In short: identity, purity, counter-ion, water content, residual solvents, microbiological safety, particulates, elemental impurities, stability, and documentation form the backbone; the intended use determines how deep each test must go.